Characterization of omalizumab updosing patterns and predictive factors in chronic spontaneous urticaria: A prospective multicentric observational study.

Guillaume PierrardClaire BernierAurélie Du-ThanhCorina BaraAngele SoriaFlorence CastelainIsabelle Boccon-GibodFlorence HacardJuliette DelaunayLaurence de MontjoyeDelphine Staumont-SalleFrédéric Dezoteux

Published in: Allergy (2024)

One in five patient underwent updosing within just 3 months. OMA updosing is frequent in particular in cases of severe disease and low IgE blood levels.

Keyphrases

case report
early onset
drug induced